应当在初次访视后 2 至 3 周采集恢复期血清学样本,确认特异性抗体滴度是否增加到 4 倍以及确认诊断。[58]Dumler JS, Madigan JE, Pusterla N, et al. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin Infect Dis. 2007 Jul 15;45 Suppl 1:S45-51.http://www.ncbi.nlm.nih.gov/pubmed/17582569?tool=bestpractice.com[60]Olano J, Walker DH. Current recommendations for diagnosis and treatment of human ehrlichiosis. Infect Med. 2002;19:318-325.[66]Olano JP, Walker DH. Human ehrlichioses. Med Clin North Am. 2002 Mar;86(2):375-92.http://www.ncbi.nlm.nih.gov/pubmed/11982308?tool=bestpractice.com[90]Olano JP. Human ehrlichioses. In: Raoult D, Parola, P, ed. Rickettsial diseases. New York, NY: Informa Healthcare USA; 2007:213-222. 其他任何监测都取决于患者是否出现重度疾病以及需要医学随访的并发症。